financetom
Business
financetom
/
Business
/
BMO Proxy Circular And 2023 Sustainability Reporting Suite Now Available
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Proxy Circular And 2023 Sustainability Reporting Suite Now Available
Mar 7, 2024 12:07 PM

02:31 PM EST, 03/07/2024 (MT Newswires) -- BMO (BMO.TO) Thursday announced that it has filed its 2024 Notice of Annual Meeting of Shareholders and Management Proxy Circular with applicable securities regulators, along with the release of its 2023 Sustainability reporting suite.

BMO's Annual Meeting of Shareholders will be held on April 16, 2024, at 9:30 a.m. EDT, and will be held virtually and in person at BMO Institute for Learning, in Toronto, Ont.

The circular and annual report can be found on the BMO Annual Meeting website at www.bmo.com/annualmeeting.

BMO encourages shareholders to vote by proxy as early as possible to ensure their shares are represented at the meeting. Shareholders can join the meeting and ask questions in person or through a live webcast or listen by teleconference.

Shareholders can access the webcast platform, related instructions and dial-in information (listen only) on the Annual Meeting website.

The 2023 Sustainability reporting suite discloses BMO's approach to managing the most relevant sustainability issues for the bank, as it pursues long term value creation and effective risk management. The report also includes the Public Accountability Statements for Bank of Montreal ( NRGD ) and its applicable subsidiaries: Bank of Montreal Mortgage Corporation, BMO Life Assurance Company and BMO Life Insurance Company.

The Sustainability reporting suite can be downloaded at: our-impact.bmo.com/reports

Price: 125.84, Change: +0.83, Percent Change: +0.66

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Scotiabank Previews Friday's Bank of Canada Senior Loan Officer Survey
Scotiabank Previews Friday's Bank of Canada Senior Loan Officer Survey
Feb 14, 2025
08:50 AM EST, 02/14/2025 (MT Newswires) -- The Bank of Canada's Senior Loan Officer Opinion Survey is due out for its quarterly update at 10:30 a.m. ET Friday, noted Scotiabank. It will sample conditions toward the end of calendar Q4 and as such is going to be partly stale on arrival, said the bank. Still, watch for any potential effects...
Oil Rises as Trump Promises to End Russia War on Ukraine and Makes More Tariff Threats
Oil Rises as Trump Promises to End Russia War on Ukraine and Makes More Tariff Threats
Feb 14, 2025
08:46 AM EST, 02/14/2025 (MT Newswires) -- Oil prices rose early on Friday following two days of losses as traders gauge the latest moves from the U.S. Administration, which is promising to end Russia's war on Ukraine while threatening widespread tariffs on the country's trading partners. West Texas Intermediate crude oil for March delivery was last seen up US$0.70 to...
Engine maker Safran upbeat on Boeing 737 MAX production this year
Engine maker Safran upbeat on Boeing 737 MAX production this year
Feb 14, 2025
* Safran CEO says Boeing ( BA ) had a 'very good start' to the year * Olivier Andries sees 737 MAX production at 42 a month by year-end * Boeing ( BA ) has a 'three-digit' stockpile of LEAP-1B engines, he says PARIS, Feb 14 (Reuters) - The head of French jet engine maker Safran said on Friday he...
Arcturus Therapeutics Says EU Commission Approves COVID-19 Vaccine Kostaive
Arcturus Therapeutics Says EU Commission Approves COVID-19 Vaccine Kostaive
Feb 14, 2025
08:47 AM EST, 02/14/2025 (MT Newswires) -- Arcturus Therapeutics ( ARCT ) said Friday the European Commission granted marketing authorization for Kostaive, a self-amplifying mRNA COVID-19 vaccine for individuals aged 18 and above. The biotechnology company said Kostaive is the first self-amplifying mRNA COVID vaccine to receive European Commission clearance and is currently marketed in Japan against the disease. Kostaive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved